C-kit and PDGFRA gene mutations in triple negative breast cancer.
about
Current advances in biomarkers for targeted therapy in triple-negative breast cancerNovel therapeutic strategies in the treatment of triple-negative breast cancer.Immunoglobulin superfamily genes are novel prognostic biomarkers for breast cancer.Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study.
P2860
C-kit and PDGFRA gene mutations in triple negative breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@ast
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@en
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@nl
type
label
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@ast
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@en
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@nl
prefLabel
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@ast
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@en
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@nl
P2093
P2860
P1476
C-kit and PDGFRA gene mutations in triple negative breast cancer.
@en
P2093
Henghui Ma
Jiandong Wang
Xiaojun Zhou
Zhihong Zhang
P2860
P304
P577
2014-06-15T00:00:00Z